Ocular Hypertension

Showing NaN - NaN of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)

Recruiting
  • Ocular Hypertension
  • Latanoprostene Bunod
  • Placebo
  • Rochester, Minnesota
    Bausch Site 001
Sep 29, 2022

Ocular Hypertension Trial in Rochester (Scleral Lens)

Recruiting
  • Ocular Hypertension
  • Scleral Lens
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Apr 1, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Brimonidine Tartrate Ophthalmic Suspension, Brimonidine

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Brimonidine Tartrate Ophthalmic Suspension
  • Brimonidine Tartrate Ophthalmic Solution
  • Chandler, Arizona
  • +46 more
Jan 27, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • DE-126 Ophthalmic Solution 0.002% QD
  • Timolol Maleate Ophthalmic Solution 0.5% BID
  • Chandler, Arizona
  • +40 more
Feb 10, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Sep 14, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Birmingham, Alabama
  • +63 more
Feb 17, 2021

Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Latanoprost ophthalmic solution
  • +2 more
  • Inglewood, California
  • +20 more
Jan 13, 2021

Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)

Completed
  • Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +28 more
Dec 11, 2020

Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost

Completed
  • Primary Open Angle Glaucoma
  • +3 more
  • PF-03187207 and Latanoprost Vehicle
  • Latanoprost 0.005% and PF-03187207 Vehicle
  • Artesia, California
  • +18 more
Sep 10, 2020

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Phoenix, Arizona
  • +105 more
May 29, 2020

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • bimatoprost 20 µg generation 2
  • +6 more
  • Artesia, California
  • +56 more
Mar 27, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Phentolamine Mesylate Ophthalmic Solution 1%
  • Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
  • Mission Hills, California
  • +4 more
Oct 10, 2019

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG324 Ophthalmic Solution 0.01%
  • +3 more
  • Artesia, California
  • +22 more
May 14, 2019

Open-Angle Glaucoma, Ocular Hypertension Trial in Rochester (BOL-303259-X, Timolol)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Rochester, New York
    Bausch & Lomb Inc.
Oct 25, 2018

Open-Angle Glaucoma, Ocular Hypertension Trial in Rochester (BOL-303259-X, Timolol)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Rochester, New York
    Bausch & Lomb Inc.
Oct 10, 2018

Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • DE-117 Low Dose ophthalmic solution
  • +5 more
  • Chandler, Arizona
  • +13 more
Apr 16, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +3 more
  • Newport Beach, California
  • +10 more
Mar 19, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +2 more
  • Artesia, California
  • +21 more
Mar 19, 2018

Glaucoma, Ocular Hypertension Trial in United States (0.25% AR-12286 / 0.004% travoprost, 0.5% AR-12286, 0.004% travoprost,

Completed
  • Glaucoma
  • Ocular Hypertension
  • 0.25% AR-12286 / 0.004% travoprost
  • +2 more
  • Inglewood, California
  • +8 more
Sep 12, 2016

Glaucoma, Ocular Hypertension, Eye Disease Trial in United States (AMA0076, Placebo)

Completed
  • Glaucoma
  • +2 more
  • Artesia, California
  • +8 more
Jan 16, 2015

Glaucoma, Ocular Hypertension Trial in United States (Latanoprost 0.005%, AR-12286 Ophthalmic Solution 0.5%, Timolol maleate

Completed
  • Glaucoma
  • Ocular Hypertension
  • Latanoprost 0.005%
  • +2 more
  • New Haven, Connecticut
  • +14 more
Apr 18, 2014

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG286 Ophthalmic Solution 0.5%
  • +2 more
  • Artesia, California
  • +20 more
Feb 17, 2014

Glaucoma, Open-Angle, Ocular Hypertension Trial in Rochester (AGN-210669 ophthalmic solution, 0.1%, AGN-210669 ophthalmic

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • AGN-210669 ophthalmic solution, 0.1%
  • +3 more
  • Rochester, New York
    (unnamed)
Aug 13, 2013

Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • No Treatment
  • Rochester, New York
    (unnamed)
Jul 16, 2013